Ryan Madder is a Cardiology physician affiliated with Beaumont Hospital. OpenAlex indexes 219 publications with 2,493 citations (h-index 27); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Clinical Evaluation of Radiation Reduction for Optimized Safety
Sponsor: Angiowave Imaging
- Intracoronary Imaging With NIRS-IVUS to Characterize Arterial Plaques
Sponsor: Corewell Health West
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
35 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.9%Statin25.2%Rosuvastatin Calcium50%Atorvastatin Calcium47%Pravastatin Sodium3%Part D<11 patientsBeta blocker20.8%Metoprolol Succinate55%Carvedilol27%Metoprolol Tartrate18%Part D≥76 patients+ 12 more classes in this area
Blood & clotting
12%Factor Xa inhibitor9.1%Eliquis66%Xarelto34%Part D≥33 patientsP2Y12 inhibitor2.9%Clopidogrel66%Brilinta34%Part D<11 patientsMetabolism & gastrointestinal
4.1%Potassium supplement3.4%Potassium Chloride100%Part D≥28 patientsSGLT2 inhibitor0.7%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- International multispecialty consensus statement and expert opinion of best practices in telesurgery
Journal of Robotic Surgery
2025 - First-in-Human Experience With a Novel Multimodality DeepOCT-NIRS Intracoronary Imaging System
Journal of the Society for Cardiovascular Angiography & Interventions
2024 - Contemporary Trends and Outcomes of Intravascular Lithotripsy in Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions
2024
Similar KOLs
Other experts from the same institution or the same specialty.
John P. Burke
Beaumont Hospital
Gilbert Raff
Beaumont Hospital
Robert Safian, MD
Beaumont Hospital
Michael A. Farrell
Beaumont Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”